Literature DB >> 9895400

Treatment of asthma with drugs modifying the leukotriene pathway.

J M Drazen1, E Israel, P M O'Byrne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9895400     DOI： 10.1056/NEJM199901213400306

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  143 in total

Review 1.  For and against. Should steroids be the first line treatment for asthma?

Authors:  G Strube; M Rudolf
Journal:  BMJ       Date:  2000-01-01

Review 2.  Leukotriene receptor antagonist therapy.

Authors:  O J Dempsey
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

Review 3.  Update in internal medicine.

Authors:  F López-Jiménez; M Brito; Y W Aude; P Scheinberg; M Kaplan; D A Dixon; N Schneiderman; J F Trejo; L H López-Salazar; E J Ramírez-Barba; R Kalil; C Ortiz; J Goyos; A Buenaño; S Kottiech; G A Lamas
Journal:  Arch Med Res       Date:  2000 Jul-Aug       Impact factor: 2.235

Review 4.  Recent advances: Respiratory medicine.

Authors:  H A Kerstjens; H J Groen; W van Der Bij
Journal:  BMJ       Date:  2001-12-08

5.  The aspirin disease.

Authors:  D Schiavino; E Nucera; A Milani; M Del Ninno; A Buonomo; J Sun; G Patriarca
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 6.  Asthma--the changing face of drug therapy.

Authors:  J Legg; J Warner
Journal:  Indian J Pediatr       Date:  2000-02       Impact factor: 1.967

Review 7.  Anti-leukotrienes in asthma: yet to arrive.

Authors:  G Gupta
Journal:  Indian J Pediatr       Date:  2000-02       Impact factor: 1.967

8.  Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations.

Authors:  Susanna L Lundström; Rohit Saluja; Mikael Adner; Jesper Z Haeggström; Gunnar Nilsson; Craig E Wheelock
Journal:  J Lipid Res       Date:  2012-10-03       Impact factor: 5.922

Review 9.  Use of modulators of airways inflammation in patients with CF.

Authors:  Clement L Ren
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

10.  Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity.

Authors:  Suzy A A Comhair; Weiling Xu; Sudakshina Ghosh; Frederik B J M Thunnissen; Alexandru Almasan; William J Calhoun; Allison J Janocha; Lemin Zheng; Stanley L Hazen; Serpil C Erzurum
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.